Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls

As Johnson & Johnson and partner Legend Biotech struggle to meet demand for their CAR-T therapy Carvykti in the U.S., the companies seem to be pacing themselves with launches outside of the key market.